• Profile
Close

Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study

Liver International Dec 04, 2020

Kim TH, Seo YS, Kang SH, et al. - In patients with decompensated cirrhosis, researchers assessed the best serum and urine markers to assess their prognosis in this prospective observational analysis. Hospitalized cases of decompensated cirrhosis were examined by obtaining measurements of serum creatinine and cystatin C (CysC), and urinary N‐acetyl‐beta‐D glucosaminidase (uNAG) and neutrophil gelatinase‐associated lipocalin levels. Independent predictors of acute kidney injury (AKI), as found in multivariate analysis, were serum CysC and uNAG levels, with optimal cut‐off values of 1.055 mg/L and 23.1 U/g urinary Cr, respectively. On grouping patients into three categories, using these cut‐off values (group 1, both low; group 2, one of two high; and group 3, both high), experts found significant differences in progression of AKI during hospitalization, incidence of AKI in patients without AKI at baseline and death rate, according to serum CysC and uNAG concentrations. Overall, experts concluded the usefulness of serum CysC and uNAG levels as prognostic markers for renal outcomes and mortality in patients suffering from decompensated cirrhosis.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay